title: Biomarkers and heart disease.
abstract: This review will focus on the evaluation of biomarkers and surrogate endpoints in chronic disease risk with a focus on cardiovascular disease. It provides an example of how identification of relevant biomarkers might be useful in sleep research and clinical care. Much of this review is derived from work performed by the Institute of Medicine (IOM) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease (see footnote in the Acknowledgments). This discussion will review the committee charge, definitions of biomarkers and other endpoints, biomarker evaluation framework, case studies of representative biomarkers, recommendations, and conclusions.
authors: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. maalbert@partners.org
authors: Michelle A
authors: MA
authors: Albert
mesh_terms: D015415:Biomarkers; D001794:Blood Pressure; D002097:C-Reactive Protein; D002784:Cholesterol; D019317:Evidence-Based Medicine; D006331:Heart Diseases / Q000175:diagnosis*; D006801:Humans; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D014481:United States; D018879:Ventricular Premature Complexes
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein; D002784:Cholesterol